RENACIDIN IRRIGATION Rx
Generic Name and Formulations:
Citric acid 6.602g, glucono-delta-lactone 198mg, magnesium carbonate 3.177g; per 100mL; irrigation soln (pH 3.85).
Indications for RENACIDIN IRRIGATION:
Dissolution of renal or bladder calculi composed of apatite or struvite in select patients. Adjunct to dissolve apatite or struvite calculi after surgery or to achieve partial dissolution prior to surgical removal. Prevention of incrustations of indwelling urinary tract catheters.
Renal calculi: Irrigate with sterile saline at 60mL/hr after fourth or fifth post-operative day and increase until pain, elevated pressure or a maximum of 120mL/hr is achieved; then start Renacidin at max rate achieved with saline. Bladder calculi: 30mL through urinary catheter into bladder, clamp for 30–60 minutes, drain bladder; repeat 4–6 times a day. Catheter incrustation: 30mL through catheter, clamp for 10 minutes, drain; repeat 3 times daily.
UTIs (obtain urine culture prior to use). Urinary tract extravasation.
Monitor magnesium, phosphate, serum creatinine, intrapelvic pressure, and for UTI or catheter obstruction; discontinue if these increase or severe urothelial edema on X-ray occur. Impaired renal function. Maintain catheter patency. Elderly. Pregnancy (Cat.C). Nursing mothers.
Concomitant magnesium: not recommended.
Transient flank pain, urthelial ulceration and/or edema, fever, UTI, back pain, dysuria, transient hematuria, nausea, hypermagnesemia, hyperphosphatemia, elevated serum creatinine, candidiasis, bladder irritation.
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency